Active — Not RecruitingNot Applicable

The UPbeating GReek Application of DancE in Parkinson's Disease Clinical Trial

Greece40 participantsStarted 2023-05-02

Plain-language summary

Dance for Parkinson's Disease® (DfPD®) is a specially designed dance program for individuals with PD. This study assesses the efficacy, safety and feasibility of a culturally adapted DfPD® program offered both live and online in Greek PD patients. A total of 40 early-to-mid-stage PD Greek patients have been enrolled to underwent a total of 16 60-min classes twice weekly over 8 weeks both live and online as well as to be part of the non-intervention control group in a 3-arms crossover randomized controlled clinical trial. Assessments will be performed at baseline and at the end of each study period and will include quality of life, fatigue, depressive symptoms, stress, anxiety, sarcopenia, frailty, balance, cognitive functions, movement and non-movement PD symptoms, and Body Mass Index (BMI). Safety and feasibility of each of the dance interventions (live DfPD® vs remote DfPD®) will be assessed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years old * An established diagnosis of idiopathic PD of an early-to-moderate severity; that is from 0 to 2,5 according to Hoehn and Yahr (H\&Y) stages * Ability to understand, write, and speak in Greek * Written consent for participating into the study * Smart device (either smart phone or tablet/laptop/computer) access for the dance intervention which will be conducted remotely Exclusion Criteria: * A diagnosis of a non-PD tremor disorder * Moderate-to-severe PD (≥3 H\&Y stages), due to a high falls risk * Serious health or disability issues (either physical or mental), due of which exercise is not permitted and/or basic instructions during the program cannot be followed * Mental disorder not related to PD * Any disease other than PD, which could affect mobility levels * Any electronic internal medical device or implant, such as a pacemaker or a deep brain stimulation, due to contraindication in the use of bio-electrical impedance analysis * No access of the participant or patient's carer to any smart device (either smart phone or tablet/laptop/computer)

What they're measuring

Change in total score of Parkinson's Disease Questionnaire-8 (PDQ-8)

Timeframe: Baseline, 10 weeks, 19 weeks, 28 weeks, 37 weeks, and 46 weeks.

Trial details

NCT IDNCT06220084

SponsorUniversity of West Attica

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-11